Instead, IFN-γ has an antifibrosis effect, with hyposecretion in IPF and the pulmonary fibrosis model of rats (Vu et al., 2019b; Maeyama et al., 2020). This evidence concerns the gene IFNG and idiopathic pulmonary fibrosis.